- Home
- NRXS vs SXTC Comparison
NRXS vs SXTC Comparison
Compare NRXS & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- SXTC
- Stock Information
- Founded
- NRXS 2011
- SXTC 2005
- Country
- NRXS United States
- SXTC China
- Employees
- NRXS N/A
- SXTC N/A
- Industry
- NRXS
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- NRXS
- SXTC Health Care
- Exchange
- NRXS Nasdaq
- SXTC Nasdaq
- Market Cap
- NRXS 13.0M
- SXTC 14.0M
- IPO Year
- NRXS 2023
- SXTC 2019
- Fundamental
- Price
- NRXS $2.27
- SXTC $1.67
- Analyst Decision
- NRXS
- SXTC
- Analyst Count
- NRXS 0
- SXTC 0
- Target Price
- NRXS N/A
- SXTC N/A
- AVG Volume (30 Days)
- NRXS 29.8K
- SXTC 12.1M
- Earning Date
- NRXS 05-12-2025
- SXTC 01-01-0001
- Dividend Yield
- NRXS N/A
- SXTC N/A
- EPS Growth
- NRXS N/A
- SXTC N/A
- EPS
- NRXS N/A
- SXTC 20.77
- Revenue
- NRXS $2,934,945.00
- SXTC $1,818,404.00
- Revenue This Year
- NRXS $138,883.78
- SXTC N/A
- Revenue Next Year
- NRXS $118.59
- SXTC N/A
- P/E Ratio
- NRXS N/A
- SXTC $0.10
- Revenue Growth
- NRXS 27.52
- SXTC 6.78
- 52 Week Low
- NRXS $1.33
- SXTC $0.30
- 52 Week High
- NRXS $3.78
- SXTC $5.70
- Technical
- Relative Strength Index (RSI)
- NRXS 54.13
- SXTC 44.85
- Support Level
- NRXS $1.94
- SXTC $1.74
- Resistance Level
- NRXS $2.42
- SXTC $2.21
- Average True Range (ATR)
- NRXS 0.26
- SXTC 0.52
- MACD
- NRXS 0.01
- SXTC 0.00
- Stochastic Oscillator
- NRXS 60.45
- SXTC 35.47
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.